# Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference
Canonical URL: https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-a-bladder-cancer-panel-at-the-btig-virtual-biote-960627c0
Ticker: IPHA
Company: Innate Pharma
Source: Innate Pharma
Published: 2026-07-22 11:17 EST
Original Source URL: https://www.innate-pharma.com/media/all-press-releases/innate-pharma-participate-bladder-cancer-panel-btig-virtual-biotechnology-conference
## Summary

Thu, 07/23/2026 - 07:00 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, toda...

## Article Body
Thu, 07/23/2026 - 07:00

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that Sonia Quaratino, EVP Chief Medical Officer of Innate Pharma, will participate in the panel discussion, Changing Treatment Landscape in Bladder Cancer, at the BTIG Virtual Biotechnology Conference.

BTIG Virtual Biotechnology Conference 2026

Panel discussion: Changing Treatment Landscape in Bladder Cancer

Date and time: July 28, 2026, 10:30 a.m. EDT / 4:30 p.m. CEST
## Recent Company News
- 2026-07-22 11:17 EST — [Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-a-bladder-cancer-panel-at-the-btig-virtual-biote-960627c0) — Source: Innate Pharma
- 2026-07-20 14:53 EST — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f) — Source: Innate Pharma
- 2026-05-21 17:08 EST — [Outcome of Innate Pharma’s 2026 Annual General Meeting](https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting) — Source: Innate Pharma
- 2026-05-18 11:27 EST — [Innate Pharma to participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference) — Source: Innate Pharma
- 2026-05-12 13:48 EST — [Innate Pharma Reports First Quarter 2026 Business Update and Financial Results](https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results) — Source: Innate Pharma
## Related News
- 2026-07-22 21:05 EST — SUPN — [Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-announce-second-quarter-2026-financial-results-and-h-58b4f63d)
- 2026-07-22 20:15 EST — MOH — [Molina Healthcare Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/MOH/molina-healthcare-reports-second-quarter-2026-financial-results-343e2d32)
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)